Holen Sie sich die Stockscreener-App
35.45
0.87%
-0.31
Handel nachbörslich:
36.15
0.70
+1.97%
Schlusskurs vom Vortag:
$35.76
Offen:
$35.76
24-Stunden-Volumen:
489.98K
Relative Volume:
0.76
Marktkapitalisierung:
$2.04B
Einnahmen:
$681.88M
Nettoeinkommen (Verlust:
$122.63M
KGV:
16.80
EPS:
2.11
Netto-Cashflow:
$220.18M
1W Leistung:
-3.38%
1M Leistung:
+10.85%
6M Leistung:
-8.68%
1J Leistung:
+4.82%
1-Tages-Spanne:
$35.38
$36.33
1-Wochen-Bereich:
$35.38
$37.59
52-Wochen-Spanne:
$26.47
$41.61
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
Firmenname
Harmony Biosciences Holdings Inc
Sektor
Branche
Telefon
(484) 539-9800
Adresse
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
Vergleichen Sie HRMY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
35.45 | 2.15B | 681.88M | 122.63M | 220.18M | 2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.41 | 120.60B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.14 | 60.80B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
330.55 | 42.87B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
598.79 | 36.23B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
305.74 | 31.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-21 | Eingeleitet | Truist | Buy |
| 2025-07-10 | Fortgesetzt | Goldman | Neutral |
| 2025-06-02 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-02-11 | Eingeleitet | Deutsche Bank | Buy |
| 2024-12-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-10-10 | Fortgesetzt | Raymond James | Outperform |
| 2024-09-10 | Eingeleitet | UBS | Buy |
| 2024-06-21 | Eingeleitet | Citigroup | Buy |
| 2024-01-02 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-09-25 | Herabstufung | Goldman | Neutral → Sell |
| 2023-09-07 | Eingeleitet | Berenberg | Buy |
| 2023-04-20 | Eingeleitet | BofA Securities | Neutral |
| 2022-10-14 | Hochstufung | Janney | Neutral → Buy |
| 2022-10-14 | Hochstufung | Jefferies | Hold → Buy |
| 2022-08-03 | Herabstufung | Jefferies | Buy → Hold |
| 2022-07-13 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-04-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-12-01 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-04 | Eingeleitet | Raymond James | Outperform |
| 2021-09-23 | Eingeleitet | Needham | Buy |
| 2021-03-29 | Hochstufung | Goldman | Neutral → Buy |
| 2020-09-14 | Eingeleitet | Goldman | Neutral |
| 2020-09-14 | Eingeleitet | Jefferies | Buy |
| 2020-09-14 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Harmony Biosciences Holdings Inc Aktie (HRMY) Neueste Nachrichten
Harmony Biosciences Holdings, Inc. (HRMY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
Are Bears Losing Grip on Harmony Biosciences Holdings Inc.Alpha Focused Technical Trade Signals Gain Attention - metal.it
Can Harmony Biosciences Holdings Inc. Regain Momentum After BreakdownCapital Growth With Controlled Risk Picks Suggested - metal.it
What are the technical indicators suggesting about Harmony Biosciences Holdings Inc.Capitalize on market momentum for profits - jammulinksnews.com
When is Harmony Biosciences Holdings Inc. stock expected to show significant growthInvest smarter with expert trading signals - jammulinksnews.com
Should I hold or sell Harmony Biosciences Holdings Inc. stock in 2025Achieve rapid portfolio growth with expert guidance - jammulinksnews.com
What are analysts’ price targets for Harmony Biosciences Holdings Inc. in the next 12 monthsFree Stock Market Forecast Reports - jammulinksnews.com
Published on: 2025-07-28 01:23:24 - jammulinksnews.com
Why Harmony Biosciences Holdings Inc. stock attracts strong analyst attentionDaily Breakout Picks - metal.it
Are Strong Financial Prospects The Force That Is Driving The Momentum In Harmony Biosciences Holdings, Inc.'s NASDAQ:HRMY) Stock? - 富途牛牛
Why is Harmony Biosciences Holdings Inc. stock attracting strong analyst attentionBreakout portfolio performance - jammulinksnews.com
What analysts say about Harmony Biosciences Holdings Inc. stockFree Stock Index Interpretation - PrintWeekIndia
What drives Harmony Biosciences Holdings Inc. stock priceOutstanding growth strategies - Autocar Professional
Is Harmony Biosciences Holdings Inc. a good long term investmentSkyrocketing investment returns - Autocar Professional
How high can Harmony Biosciences Holdings Inc. stock price go in 2025Free Stock Market Query - jammulinksnews.com
Harmony Biosciences to Report Second Quarter 2025 Financial Results on August 5, 2025 - MarketScreener
Most Volatile Stocks in the US (July 2025) - Investing.com
Harmony Biosciences Advances Pipeline While Navigating Analyst Caution - Insider Monkey
Harmony Biosciences Holdings Inc. Stock Analysis and ForecastBreakout stock performance - jammulinksnews.com
Harmony Biosciences to Report Second Quarter 2025 Financial Resu - GuruFocus
13 Best Low Risk High Growth Stocks to Buy - Insider Monkey
Truist Securities initiates Harmony Biosciences stock with Buy rating - Investing.com
Truist Securities initiates Harmony Biosciences stock with Buy rating By Investing.com - Investing.com India
Truist Securities Initiates Coverage on Harmony Biosciences (HRM - GuruFocus
H.C. Wainwright reiterates Buy rating on Harmony Biosciences stock By Investing.com - Investing.com Nigeria
H.C. Wainwright reiterates Buy rating on Harmony Biosciences stock - Investing.com
Truist Securities Starts Harmony Biosciences Holdings Inc. (HRMY) at Buy - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY) - StreetInsider
Truist Initiates Buy Rating for Harmony Biosciences (HRMY) with Promising Growth Prospects | HRMY Stock News - GuruFocus
Why Harmony Biosciences (HRMY) is Poised to Beat Earnings Estimates Again - MSN
Finanzdaten der Harmony Biosciences Holdings Inc-Aktie (HRMY)
Umsatz
Nettogewinn
Free Cashflow
ENV
10.28%
2.59%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):